NEW YORK--(BUSINESS WIRE)--May 12, 2006--Daxor Corporation (AMEX:DXR - News), a medical instrumentation and biotechnology company, today announced the receipt of a signed trial agreement from the University of Pittsburgh Medical Center (UPMC) of Pittsburgh, Pennsylvania.
